calmidazolium has been researched along with Carcinoma, Hepatocellular in 2 studies
calmidazolium: powerful inhibitor of or red blood cell Ca++-ATPase & Ca++ transport into inside-out red blood cell vesicles; RN refers to chloride; structure in first source; an antagonist of calmodulin
calmidazolium : An imidazolium ion that is imidazolium cation substituted by a bis(4-chlorophenyl)methyl group at position 1 and a 2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl group at position 3. It acts as an antagonist of calmodulin, a calcium binding messenger protein.
Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Collectively, in HA59T hepatoma cells, calmidazolium induced [Ca2+]i rises by causing Ca2+ release from the endoplasmic reticulum in a phospholipase C-independent manner, and Ca2+ influx via protein kinase C-regulated Ca2+ entry pathway." | 1.35 | Effect of calmidazolium on [Ca2+]i and viability in human hepatoma cells. ( Chai, KL; Chang, HT; Cheng, HH; Cheng, JS; Chou, CT; Fang, YC; Hsu, PT; Huang, CC; Huang, JK; Jan, CR; Liao, WC; Lin, KL; Lu, YC; Tsai, JY; Wang, JL, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liao, WC | 1 |
| Huang, CC | 1 |
| Cheng, HH | 1 |
| Wang, JL | 1 |
| Lin, KL | 1 |
| Cheng, JS | 1 |
| Chai, KL | 1 |
| Hsu, PT | 1 |
| Tsai, JY | 1 |
| Fang, YC | 1 |
| Lu, YC | 1 |
| Chang, HT | 1 |
| Huang, JK | 1 |
| Chou, CT | 1 |
| Jan, CR | 1 |
| Said, HM | 1 |
| Ortiz, A | 1 |
| Ma, TY | 1 |
| McCloud, E | 1 |
2 other studies available for calmidazolium and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Effect of calmidazolium on [Ca2+]i and viability in human hepatoma cells.
Topics: Apoptosis; Calcium; Calcium Signaling; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; D | 2009 |
Riboflavin uptake by the human-derived liver cells Hep G2: mechanism and regulation.
Topics: Antiemetics; Biological Transport; Bucladesine; Calcium; Calmodulin; Carcinogens; Carcinoma, Hepatoc | 1998 |